España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Zentalis Pharma
ZNTL
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$3.19
-0.03
-0.93%
At close: -
$3.18
-0.01000
-0.31%
After Hours: 4:23 PM EDT
Get Report
Comment
Zentalis Pharma (ZNTL) Forecast
News
Earnings
Zentalis Pharma (ZNTL) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Zentalis Pharma (NASDAQ:ZNTL) Stock
Zentalis Pharma Stock (NASDAQ: ZNTL)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, November 15, 2024
Zentalis Pharmaceuticals shares are trading l...
Benzinga Newsdesk
Guggenheim Maintains Buy on Zentalis Pharma, ...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Zentali...
Benzinga Newsdesk
Wednesday, November 13, 2024
Zentalis Pharmaceuticals shares are trading h...
Benzinga Newsdesk
Zentalis Pharmaceuticals Announces Julie East...
Benzinga Newsdesk
Monday, September 16, 2024
Oppenheimer Reiterates Outperform on Zentalis...
Benzinga Newsdesk
FDA Removes Partial Hold On Zentalis Pharmaceuticals' Azenosertib Studies In Patients With Gynecological Cancers
Vandana Singh
Market-Moving News for September 16th
Benzinga Newsdesk
Zentalis Pharmaceuticals shares are trading h...
Benzinga Newsdesk
Zentalis Says It Remains On Track To Meet All...
Benzinga Newsdesk
Zentalis Says FDA Has Lifted Partial Clinical...
Benzinga Newsdesk
Monday, August 12, 2024
Wedbush Upgrades Zentalis Pharma to Neutral, ...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Zentali...
Benzinga Newsdesk
Friday, August 09, 2024
Zentalis Pharma Q2 EPS $(1.24) Misses $(0.84)...
Benzinga Newsdesk
Friday, June 21, 2024
(ZNTL) - Analyzing Zentalis Pharma's Short Interest
Benzinga Insights
Thursday, June 20, 2024
UBS Downgrades Zentalis Pharma to Neutral, Lo...
Benzinga Newsdesk
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Zentalis Pharmaceuticals shares are trading h...
Benzinga Newsdesk
Wednesday, June 19, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Tuesday, June 18, 2024
Wells Fargo Downgrades Zentalis Pharma to Equ...
Benzinga Newsdesk
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Stifel Maintains Buy on Zentalis Pharma, Lowe...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Zentalis...
Benzinga Newsdesk
Oppenheimer Maintains Outperform on Zentalis ...
Benzinga Newsdesk
Morgan Stanley Downgrades Zentalis Pharma to ...
Benzinga Newsdesk
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Why Is Small-Cap Cancer-Focused Zentalis Pharma Stock Trading Lower On Tuesday?
Vandana Singh
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Zentalis Pharmaceuticals shares are trading l...
Benzinga Newsdesk
Trading Halt: Halt status updated at 7:25:00 ...
Benzinga Newsdesk
Zentalis Pharmaceuticals Announced That FDA H...
Benzinga Newsdesk
Trading Halt: Halted at 6:56:04 a.m. ET - Tra...
Benzinga Newsdesk
Wednesday, May 08, 2024
HC Wainwright & Co. Maintains Buy on Zentalis...
Benzinga Newsdesk
Stifel Maintains Buy on Zentalis Pharma, Lowe...
Benzinga Newsdesk
Tuesday, May 07, 2024
Zentalis Pharma's Q1 Cash, Cash Equivalents a...
Benzinga Newsdesk
Zentalis Pharma Q1 2024 GAAP EPS $0.14 May No...
Benzinga Newsdesk
Thursday, April 11, 2024
Zentalis Pharmaceuticals shares are trading l...
Benzinga Newsdesk
Tuesday, April 02, 2024
Zentalis Pharmaceuticals To Highlight Preclin...
Benzinga Newsdesk
Thursday, March 28, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Wednesday, February 28, 2024
HC Wainwright & Co. Reiterates Buy on Zentali...
Benzinga Newsdesk
Zentalis Pharmaceuticals shares are trading h...
Benzinga Newsdesk
Wedbush Maintains Neutral on Zentalis Pharma,...
Benzinga Newsdesk
Tuesday, February 27, 2024
Zentalis Pharma FY EPS $(4.47) Up From $(4.48...
Benzinga Newsdesk
Monday, January 08, 2024
Immunome, Zentalis Enter Exclusive, Worldwide...
Benzinga Newsdesk
Tuesday, November 14, 2023
Board Member of Zentalis Pharma Purchased $167K In Stock
Benzinga Insights
Wednesday, November 08, 2023
Wedbush Downgrades Zentalis Pharma to Neutral...
Benzinga Newsdesk
Tuesday, November 07, 2023
Analyst Expectations for Zentalis Pharma's Future
Benzinga Insights
Morgan Stanley Maintains Overweight Rating for Zentalis Pharma: Here's What You Need To Know
Benzinga Insights
Stifel Maintains Buy on Zentalis Pharma, Lowe...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch